Braveheart
Transforming Hypertrophic Cardiomyopathy Care
San Francisco, United States · Founded 2025 · $185.0M raised
- Headquarters
- San Francisco
- Founded
- 2025
- Business Model
- B2B
- Website
- braveheart.bio
- Total Funding
- $185.0M
- Last Round
- $185.0M Series ANov 2025
- Rounds
- 1
About
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy (HCM), a rare heart-muscle disease affecting roughly 1 in 500 people in the United States. Its lead program, BHB-1893, is a selective small-molecule cardiac myosin inhibitor designed to improve heart performance in HCM patients and is advancing through global late-stage clinical development.
Summary
Braveheart is a Healthcare company based in San Francisco, United States, founded in 2025. It has raised $185.0M in total across 1 round, most recently a $185.0M Series A round in Nov 2025. Investors include Andreessen Horowitz, Forbion Capital Partners and OrbiMed.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/braveheart"><img src="https://indexed.vc/api/badge/company/braveheart" alt="Braveheart on Indexed.vc" width="260" height="76" /></a>